Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
JCI Insight|June 22, 2023
Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejectionYun Hu, Sébastien Paris, Narayan Sahoo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2017
Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial controlYi An, Wen Jiang, Betty Y S Kim, et al.
Frontiers in Oncology|October 24, 2024
Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapyNahum Puebla-Osorio, Natalie Wall Fowlkes, Hampartsoum B Barsoumian, et al.
Molecular Cancer|February 3, 2025
Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteinsMaria Angelica Freitas-Cortez, Fatemeh Masrorpour, Hong Jiang, et al.
Nature Communications|October 29, 2014
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppressionLimo Chen, Don L Gibbons, Sangeeta Goswami, et al.
Cell|June 22, 2026
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistanceGuang Lei, Zhengze Lu, Zhihao Xu, et al.
Oncoimmunology|December 19, 2024
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7<sup>th</sup> immunorad conferencePierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2021
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trialRoshal R Patel, Kewen He, Hampartsoum B Barsoumian, et al.
Pageof 15